Cervical cancer rates are on the rise among younger women, owing in part to a lack of screening and prevention.
The international community has been called upon to scale up cervical cancer interventions and progress against the only noncommunicable disease that can be eliminated.This call was made by the ...
Genmab has received approval from the Japan's Ministry of Health, Labour and Welfare for Tivdak (tisotumab vedotin) to treat ...